Metraipolis › archive › dc_e0115e32f083
Development of a laboratory-based nomogram for predicting clinical outcomes in patients with severe COVID-19 undergoing glucocorticoid therapy — Europe PMC PMID:41426569
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41426569
- DOI
- 10.3389/fmed.2025.1635545
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T21:26:56.051Z
- SHA-256 of the archived text
76edd0420028fdc08c4b4033f7e7869380b07b3ca32dd1ea90688245c8c70e1a- Stable URL of this page
https://metraipolis.com/documento/dc_e0115e32f083
How to cite
Development of a laboratory-based nomogram for predicting clinical outcomes in patients with severe COVID-19 undergoing glucocorticoid therapy — Europe PMC PMID:41426569 — Europe PMC (en), https://europepmc.org/article/MED/41426569 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e0115e32f083 (Metraipolis archive dc_e0115e32f083, sha256 76edd0420028fdc08c4b4033f7e7869380b07b3ca32dd1ea90688245c8c70e1a)
BibTeX
@misc{dce0115e32f083,
title = {Development of a laboratory-based nomogram for predicting clinical outcomes in patients with severe COVID-19 undergoing glucocorticoid therapy — Europe PMC PMID:41426569},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41426569},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e0115e32f083; sha256 76edd0420028fdc08c4b4033f7e7869380b07b3ca32dd1ea90688245c8c70e1a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41426569. Agents can read the archived copy with the MCP tool read_document.